Phase 1 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are Japanese, either first-generation (born in Japan, with both parents and all four grandparents also born in Japan of full Japanese descent) or second-generation (born outside Japan, but with both parents and all four grandparents born in Japan of full Japanese descent).
- People whose Body Mass Index (BMI) — a number calculated from height and weight — falls between 23.0 and 35.0 at the time of the screening appointment.
Who may not be able to join:
- People whose body weight has changed by 5% or more in the three months before the screening appointment.
- People whose blood sugar levels at screening are at or above certain thresholds — specifically, an HbA1c (a measure of average blood sugar over time) of 6.5% or higher, and/or a fasting blood glucose level of 126 mg/dL or higher (confirm with trial site).
- People who have taken any medication intended to treat obesity — such as GLP-1 agonists, GLP-1/GIP agonists, bupropion-naltrexone, orlistat, metformin, phentermine-topiramate, amphetamine-based stimulants, or methylphenidate — or who have participated in an obesity-related clinical trial within the 180 days before the study treatment begins.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.